Evidence map›Paper›PMID 34885894›Full record

ReviewMolecules (Basel, Switzerland)2021

Effects of Prenatal Exposure to Aflatoxin B1: A Review.

João Victor Batista da Silva, Carlos Augusto Fernandes de Oliveira, Leandra Náira Zambelli Ramalho

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
7.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 48 citations in OpenAlex.

  1. A CYP3A7 metabolically competent human induced pluripotent stem cell-derived hepatocyte-like cell (hHLCDrug metabolism and disposition: the biological fate of chemicals · 2026
    Article
  2. Prenatal Aflatoxin BToxins · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Aflatoxin BOpen medicine (Warsaw, Poland) · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

João Victor Batista da SilvaDepartment of Pathology and Forensic Medicine, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirao Preto 14049-900, Sao Paulo, Brazil.
Carlos Augusto Fernandes de OliveiraDepartment of Food Engineering, School of Animal Science and Food Engineering, University of São Paulo, Pirassununga CEP 13635-900, Sao Paulo, Brazil.ORCID 0000-0001-5779-5287
Leandra Náira Zambelli RamalhoDepartment of Pathology and Forensic Medicine, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirao Preto 14049-900, Sao Paulo, Brazil.
Universidade de São Paulo · BR

Funding

São Paulo Research Foundation 2019/21603-1
6 · The paper itself

Abstract

Aflatoxins are mycotoxins produced as secondary fungal metabolites. Among them, aflatoxin B1 (AFB1) stands out due to its genotoxic and mutagenic potential, being a potent initiator of carcinogenesis. In this review, the outcomes from the published literature in the past 10 years on the effects of AFB1 pathophysiological mechanisms on embryological and fetal development are discussed. In several animal species, including humans, AFB1 has a teratogenic effect

Indexed as

Aflatoxin B1AnimalsDNA MethylationFemaleHumansMutagensNeoplasmsPregnancyPrenatal Exposure Delayed EffectsAflatoxin B1Mutagensaflatoxinscarcinogenicitymutagenicityprenatal exposureteratogenicity

Identifiers

PMID34885894
PMCPMC8659025
OpenAlexW3216426586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.